Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 12, 2022
Prenatal stress enhances atherosclerosis and telomere shortening in ApoE knockout mouse offspringTomoaki Ito, Harumi Saeki, Xin Guo, et al.Toxicologic Pathology|June 24, 2017
Regulatory Forum Opinion Piece*: Imaging Applications in Toxicologic Pathology-Recommendations for Use in Regulated Nonclinical Toxicity StudiesRobert R Maronpot, Abraham Nyska, Sean P Troth, et al.Molecular Cancer Therapeutics|April 17, 2014
Geranylgeranylacetone blocks doxorubicin-induced cardiac toxicity and reduces cancer cell growth and invasion through RHO pathway inhibitionPolina Sysa-Shah, Yi Xu, Xin Guo, et al.Oncotarget|July 14, 2012
A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathyDipankar Pramanik, Nathaniel R Campbell, Samarjit Das, et al.Science Advances|July 9, 2019
Imaging CAR T cell therapy with PSMA-targeted positron emission tomographyIl Minn, David J Huss, Hye-Hyun Ahn, et al.Plos One|August 8, 2013
Loss of NAC1 expression is associated with defective bony patterning in the murine vertebral axisKai Lee Yap, Polina Sysa-Shah, Brad Bolon, et al.The EMBO Journal|October 29, 2014
Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brainYusuke Kageyama, Masahiko Hoshijima, Kinya Seo, et al.Journal of Neuroinflammation|November 18, 2020
Correction to: Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infectionFarina J Mahmud, Yong Du, Elizabeth Greif, et al.Journal of Neuroinflammation|September 18, 2020
Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infectionFarina J Mahmud, Yong Du, Elizabeth Greif, et al.Chembiochem : a European Journal of Chemical Biology|July 20, 2016
An Fc-Small Molecule Conjugate for Targeted Inhibition of the Adenosine 2A ReceptorPo-Yuan Hsiao, Jay H Kalin, Im-Hong Sun, et al.Pageof 3